Bausch Health Companies (BHC) Operating Income (2009 - 2026)
Bausch Health Companies (BHC) posted Operating Income of $740.0 million for Q2 2026, up 177.89% sequentially from -$950.0 million in Q1 2026, and up 66.67% YoY from $444.0 million in Q2 2025.
Bausch Health Companies (BHC) Operating Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Operating Income for 18 years, with the latest figure at $740.0 million in Q2 2026.
- Quarterly Operating Income rose 66.67% year-over-year to $740.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $883.0 million (down 44.67% YoY) and the FY2025 annual result came in at $1.8 billion, up 17.27% from the prior year.
- Operating Income climbed to $740.0 million in Q2 2026 per BHC's latest filing, from -$950.0 million in the prior quarter.
- Over five years, Operating Income peaked at $740.0 million in Q2 2026 and troughed at -$950.0 million in Q1 2026.
- A 5-year average of $253.7 million and a median of $301.5 million in 2022 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2026: Operating Income jumped 2171.43% in 2024, then plunged 444.2% in 2026.
- Over 5 years, Operating Income stood at -$236.0 million in 2022, then jumped by 253.39% to $362.0 million in 2023, then jumped by 54.14% to $558.0 million in 2024, then slipped by 15.05% to $474.0 million in 2025, then surged by 56.12% to $740.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $740.0 million, -$950.0 million, and $474.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 740.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 740.00 Mn |
| Mar 31, 2026 | -950.00 Mn |
| Dec 31, 2025 | 474.00 Mn |
| Sep 30, 2025 | 619.00 Mn |
| Jun 30, 2025 | 444.00 Mn |
| Mar 31, 2025 | 276.00 Mn |
| Dec 31, 2024 | 558.00 Mn |
| Sep 30, 2024 | 318.00 Mn |
| Jun 30, 2024 | 389.00 Mn |
| Mar 31, 2024 | 281.00 Mn |
| Dec 31, 2023 | 362.00 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 412.00 Mn |
| Mar 31, 2023 | 175.00 Mn |
| Dec 31, 2022 | -236.00 Mn |
| Sep 30, 2022 | 244.00 Mn |
| Jun 30, 2022 | 161.00 Mn |
| Mar 31, 2022 | 285.00 Mn |
| Dec 31, 2021 | 367.00 Mn |
| Sep 30, 2021 | 574.00 Mn |